Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome

Hypertension

Volumn 55, Issue 4, 2010, Pages 813-818

  Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aldosterone; Mineralocorticoid receptor; Obesity; Rac1; Salt

Indexed keywords

ALDOSTERONE; GUANINE NUCLEOTIDE BINDING PROTEIN; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; RAC1 PROTEIN; SODIUM CHLORIDE;

ADIPOCYTE; ALBUMINURIA; ALDOSTERONE BLOOD LEVEL; DAHL SALT SENSITIVE RAT; DIASTOLIC DYSFUNCTION; HEART DISEASE; HEART INJURY; HIGH SODIUM INTAKE; HUMAN; HYPERALDOSTERONISM; HYPERGLYCEMIA; HYPERTENSION; KIDNEY INJURY; METABOLIC SYNDROME X; MICROALBUMINURIA; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALT LOADING; SODIUM URINE LEVEL; ANIMAL; METABOLISM; RAT; SALT INTAKE;

ALDOSTERONE; ANIMALS; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; RATS; RATS, INBRED DAHL; RECEPTORS, MINERALOCORTICOID; SODIUM CHLORIDE, DIETARY;

EID: 77950510305     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.149062     Document Type: Review

References (59)

1. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med. 1980;69:334-344.
2. Luft FC, Weinberger MH. Heterogenous responses to changes in dietary salt intake: the salt-sensitivity paradigm. Am J Clin Nutr. 1997;65(suppl): 612S-617S.
3. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734-1737.
4. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol. 2006;17:3438-3446.
5. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T. Salt-induced ne-phropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor. Hypertension. 2007;50: 877-883.
6. Matsui H, Ando K, Kawarazaki H, Nagae A, Fujita M, Shimosawa T, Nagase M, Fujita T. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension. 2008;52:287-294.
7. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 2008;14:1370-1376.
8. Fujita T. Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrol Dial Transplant. 2007;22:3102-3107.
9. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med. 2008;86:729-734.
10. Rocchini AP, Key J, Bondie D. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989; 321:580-585.
11. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, Sugimoto T, Nishio Y, Maegawa H, Koya D, Haneda M, Kashiwagi A. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627-1632.
12. Hall JE, Mizelle HL, Hildelbrandt DA, Brands MW. Abnormal pressure natriuresis: a cause or a consequence of hypertension? Hypertension. 1990;15:547-559.
13. Fujita T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension. 1984;6:184-192.
14. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen CS, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, Whelton PK, He J, for the GenSalt Collaborative Research Group. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373:829-835.
15. Sharma AM, Schorr U, Distler A. Insulin resistance in young normo-tensive subjects. Hypertension. 1993;21:273-279.
16. Falkner B, Hulman S, Kushner H. Hyperinsulinemia and blood pressure sensitivity to sodium in young blacks. J Am Soc Nephrol. 1992;3: 940-946.
17. Zheng Y, Yamada H, Sakamoto K, Horita S, Kunimi M, Endo Y, Li Y, Tobe K, Terauchi Y, Kadowaki T, Seki G, Fujita T. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption. J Am Soc Nephrol. 2005;16:2288-2295.
18. Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sym-pathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation. 2009;119: 978-986.
19. Hall J. Mechanism of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997;10:49S-55S.
20. Hall JE, Granger JP, Smith MJ Jr, Premen AJ. Role of renal hemody-namics and arterial pressure in aldosterone "escape." Hypertension. 1984; 6:183-192.
21. de Paula RB, da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hypertension. Hypertension. 2004;43:41-47.
22. Funder JW, Mihailidou AS. Aldosterone and mineralocorticoid receptors: clinical studies and basic biology. Mol Cell Endocrinol. 2009:301:2-6.
23. Rocha R, Chandor PN, Zuckerman A, Stier CT Jr. Role of renal vascular injury in stroke-prone hypertensive rats. Hypertension. 1999;33:232-237.
24. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.
25. Fiebeler A, Muller D, Shagdarsuren E, Luft FC. Aldosterone, mineralo-corticoid receptors, and vascular inflammation. Curr Opi Nephrol Hypertens. 2007;16:134-142.
26. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension. 2007;49:355-364.
27. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephol. 2002;13:3005-3015.
28. Chen J, Muntner P, Hamm LL, Jones DW, Batman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167-174.
29. Andronico G, Cottone S, Mangano MT, Ferraro-Mortellaro R, Baiardi G, Grassi N, Ferrara L, Mule G, Cerasola G. Insulin, renin-angiotensin system and blood pressure in obese people. Int J Obes Relat Metab Disord. 2001;25:239-242.
30. Goodfriend TL, Ball DL, Egan BM. Epoxy-keto derivative of linolic acid stimulates aldosterone secretion. Hypertension. 2004;43:358-363.
31. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol. 2004;287:R943-R949.
32. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA. 2003;100:14211-14216.
33. Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH, Kim JW, Kim D, Han SH, Lim JS, Kim KI, Yoon DY, Kim SH, Oh GT, Kim E, Yang Y. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 2008;22:1502-1511.
34. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
35. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fobrosis. J Lab Clin Med. 1992;120:893-901.
36. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac figrosis. J Clin Invest. 1994;93:2578-2583.
37. Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, Yatomi Y, Fujita T. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. J Hypertens. 2008;26:1453-1462.
38. Verhave JC, Hillege HL, Burgerhof JGM, Janssen WMT, Gansevoort RT, Navis GJ, De Zeeuw D, De Jong PE; for the PRVEND Study Group. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Inter Med. 2004;256:324-330.
39. Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension. 2006;48:239-245.
40. Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol. 2004; 93:990-996.
41. Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM. Increased exression of mineralo-corticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation. 2005;112:1435-1443.
42. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995;270:1491-1494.
43. Tronche F, Opherk C, Moriggl R, Kellendonk C, Reimann A, Schwake L, Reichardt HM, Stangl K, Gau D, Hoeflich A, Beug H, Schmidt W, Schutz G. Glucocorticoid receptor function in hepatocytes is essential to potentiate postnatal body growth. Genes Dev. 2004;18:492-497.
44. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81:153-208.
45. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F. Rac1 activation controls nuclear localization of β-catenin during canonical Wnt signaling. Cell. 2008;133:340-353.
46. Kawashima T, Kitamura T. Rac and nuclear translocation of signal transducers and activators of transcription factors. Methods Enzymol. 2008;439:171-180.
47. Jin S, Ray RM, Johnson LR. TNF-α/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am J Physiol Gastorointest Liver Physiol. 2008;294:G928-G937.
48. Kim H, Hwang JS, Woo CH, Kim EY, Kim TH, Cho KJ, Seo JM, Lee SS, Kim JH. TNF-α-induced upregulation of intercellular adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway epithelial cells. Exp Mol Med. 2008;40:167-175.
49. Satou R, Gonzalez-Villalobos RA, Miyata K, Ohashi N, Urushihara M, Acres OW, Navar LG, Kobori H. IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol. 2009; 311:24-31.
50. Tsai CT, Lai LP, Kuo KT, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Tseng YZ, Chiang FT, Lin JL. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibro-blasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation. 2008;117:344-355.
51. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-287.
52. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y, Nishiyama A. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005;16:703-711.
53. Shen E, Li Y, Li Y, Shan L, Zhu H, Feng Q, Arnold JM, Peng T. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes. 2009;58:2386-2395.
54. Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension. 2006;47:1084-1093.
55. Tzima E, Del Pozo MA, Kiosses WB, Mohamed SA, Li S, Chien S, Schwarts MAl. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J. 2002;21:6791-6800.
56. Liu WF, Nelson CM, Tan JL, Chen CS. Cadherins, RhoA, and Rac1 are differentially required for stretch-mediated proliferation in endothelial versus smooth muscle cells. Cir Res. 2007;101:e44-e52.
57. Ciano-Oliveira CD, Thirone ACP, Szaszi K, Kapus A. Osmotic stress and the cytoskeleton: theR(h) oleofRhoGTPases. Acta Physiol. 2006;187:257-272.
58. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension. 2003;41:592-597.
59. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptors in human coronary artery smooth muscle cell. Cir Res. 2005;96:643-650.